NCT02015169 2018-01-17
Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis
Samsung Medical Center
Phase 2 Completed
Samsung Medical Center
Stanford University
Eastern Hepatobiliary Surgery Hospital
Azienda Ospedaliera di Padova
University Hospital, Geneva